Antioxidant and Vasodilator Composition for Aminoglycoside-Induced Hearing Loss
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating hearing loss induced by aminoglycoside antibiotics, such as permanent deficits in the vestibular system and irreversible cell death in the cochlea, are inadequate, particularly in developing countries where monitoring is less rigorous, leading to prevalent side effects like hearing impairment and drug-resistant tuberculosis.
Innovation Solution
A composition comprising biologically effective amounts of vitamin A, vitamin E, vitamin C, magnesium, and optionally withanolide or resveratrol, administered to mammals to counteract free radical formation and vasoconstriction, providing an additive effect greater than the sum of individual components in reducing hearing loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If aminoglycoside antibiotics are used to treat severe gram-negative bacterial infections, then treatment effectiveness is improved, but hearing loss and vestibular damage occur
Solution Approach 1:
The patent introduces a composition containing antioxidants (vitamin E, vitamin C, beta-carotene) and vasodilators (magnesium, creatine) as intermediary substances that mediate between the aminoglycoside antibiotic treatment and the inner ear tissues. These intermediaries scavenge free radicals and improve blood flow to protect hair cells from antibiotic-induced damage, allowing effective treatment while preventing harmful effects.
Solution Approach 2:
The patent converts the harmful free radical formation caused by aminoglycoside antibiotics into a beneficial process by using antioxidant compounds. The free radicals that would normally cause cell death are instead scavenged by vitamin E, vitamin C, and beta-carotene, transforming the harmful oxidative stress into a controlled mechanism that protects against antibiotic toxicity while maintaining treatment efficacy.
2Object-affected harmful factors
If monitoring of aminoglycoside antibiotic treatment is rigorous, then hearing loss is minimized, but treatment accessibility is reduced
Solution Approach 1:
The patent enables the treatment system to be self-protecting by incorporating multiple protective components (antioxidants and vasodilators) directly into the treatment protocol. The composition automatically scavenges free radicals and improves blood flow without requiring external monitoring or intervention, making the protective effect inherent to the treatment itself rather than dependent on rigorous external surveillance.
Solution Approach 2:
The patent applies preliminary protective action by administering the antioxidant and vasodilator composition before and during aminoglycoside antibiotic treatment. This pre-emptive protection prevents free radical formation and vascular constriction before they can cause damage to hair cells, eliminating the need for post-damage monitoring or intervention.
3Reliability
If multiple protective components are combined in a single composition, then treatment effectiveness is improved, but formulation complexity increases
Solution Approach 1:
The patent merges multiple protective components (vitamin E, vitamin C, beta-carotene, magnesium, creatine) into a single unified composition that can be administered together. This combination approach consolidates multiple protective mechanisms into one formulation, improving reliability through synergistic effects while avoiding the complexity of managing separate protective agents.
Solution Approach 2:
The patent creates a composite treatment formulation combining antioxidant compounds and vasodilators in a single composition. This composite approach integrates multiple functional components (free radical scavenging, vascular protection, energy metabolism support) into one unified substance, achieving enhanced protective effect without proportionally increasing formulation complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly reduces hearing loss and hair cell damage, offering a promising treatment for antibiotic-induced hearing loss, with potential benefits in minimizing side effects and drug-resistant strains, and is effective even when administered after initial trauma or antibiotic treatment.
Implementation Method 1
The composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol... counteract free radical formation
Implementation Method 2
a vasodilator comprising magnesium... counteract free radical formation and vasoconstriction
Data Source
AI summary
A method of treating hearing loss includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.